Aims/hypothesis. A strong positive correlation has been found between lipid peroxidation product and vascular endothelial growth factor concentrations in the vitreous of patients with proliferative diabetic retinopathy. To establish a causal relation between diabetes-associated enhanced oxidative stress and vascular endothelial growth factor production, we evaluated two antioxidants, dl-a-lipoic acid and taurine, on retinal vascular endothelial growth factor protein and mRNA expression and on parameters of oxidative stress in streptozotocin-diabetic rats. Methods. Our experiments were on control rats and streptozotocin-diabetic rats with a 6-week duration of diabetes, treated with or without dl-a-lipoic acid (100 mg´kg ±1´d±1 , i. p.) or taurine (1 % in the diet) starting from induction of diabetes. Vascular endothelial growth factor protein in retinal homogenates was assessed by sandwich ELISA with an affinity-purified polyclonal antibody and vascular endothelial growth factor mRNA by ribonuclease protection assay. Retinal lipid peroxidation products i. e. malondialdehyde plus 4-hydroxyalkenals were quantified with n-methyl-2-phenylindole. Retinal reduced and oxidized glutathione, ascorbate, dehydroascorbate, and sorbitol pathway intermediates were measured spectrofluorometrically, and taurine by reverse-phase HPLC.
Aims/hypothesis. A strong positive correlation has been found between lipid peroxidation product and vascular endothelial growth factor concentrations in the vitreous of patients with proliferative diabetic retinopathy. To establish a causal relation between diabetes-associated enhanced oxidative stress and vascular endothelial growth factor production, we evaluated two antioxidants, dl-a-lipoic acid and taurine, on retinal vascular endothelial growth factor protein and mRNA expression and on parameters of oxidative stress in streptozotocin-diabetic rats. Methods. Our experiments were on control rats and streptozotocin-diabetic rats with a 6-week duration of diabetes, treated with or without dl-a-lipoic acid (100 mg´kg ±1´d±1 , i. p.) or taurine (1 % in the diet) starting from induction of diabetes. Vascular endothelial growth factor protein in retinal homogenates was assessed by sandwich ELISA with an affinity-purified polyclonal antibody and vascular endothelial growth factor mRNA by ribonuclease protection assay. Retinal lipid peroxidation products i. e. malondialdehyde plus 4-hydroxyalkenals were quantified with n-methyl-2-phenylindole. Retinal reduced and oxidized glutathione, ascorbate, dehydroascorbate, and sorbitol pathway intermediates were measured spectrofluorometrically, and taurine by reverse-phase HPLC.
Results. Vascular endothelial growth factor protein concentration (means SD) was increased in diabetic rats compared with control rats (33 7 vs 19 5 pg/mg total protein, p < 0.01) This increase was attenuated by taurine (26 8, p < 0.05) and prevented by dla-lipoic acid (21 4, p < 0.01). Vascular endothelial growth factor mRNA abundance was reduced by 1.4-fold in diabetic rats compared with control rats and this decrease was attenuated but not completely prevented by both antioxidants. Malondialdehyde plus 4-hydroxyalkenal concentration was increased in diabetic rats compared with control rats, and both antioxidants arrested accumulation of lipid peroxidation products. Taurine, reduced glutathione, oxidized glutathione, ascorbate, dehydroascorbate and sorbitol pathway intermediate concentrations as well as oxidized glutathione/reduced glutathione and dehydroascorbate/ascorbate ratios were similar in control and diabetic rats treated with or without taurine. Conclusion/interpretation. Oxidative stress is directly involved in up regulation of vascular endothelial growth factor protein in the retina during early diabetes. [Diabetologia (2001) 44 : 1102±1110] Keywords Ascorbate, lipid peroxidation, dl-a-lipoic acid, oxidative stress, rat, retina, sorbitol pathway of glucose metabolism, streptozotocin-diabetes, taurine, vascular endothelial growth factor. One of the most dangerous consequences of diabetes-associated ªglucose toxicityº is oxidative stress resulting from increased production of reactive oxygen species (ROS) and insufficient up regulation [9] and often down regulation [10, 11] of the antioxidative defence mechanisms. Reactive oxygen species are involved in decreased retinal blood flow [12] , increased vascular permeability and disruption of blood±retinal barrier [13, 14] , and the appearance of acellular capillaries [15, 16] from apoptotic loss of retinal capillary cells [16] . Recent findings suggest that premature apoptosis of pericytes and endothelial cells is induced by poly(ADP-ribosyl)ation [17, 18] which, in turn, is caused by hydroxyl radicals [19] and peroxynitrite [20] formed in the reaction of superoxide anion radicals with nitric oxide. Furthermore, in vitro studies [14, 21±23] implicate oxidative stress in the excessive production of vascular endothelial growth factor (VEGF) which is associated with increased vascular permeability and disruption of blood±retinal barrier [7, 13, 24] in background diabetic retinopathy as well as neovascularization [25, 26] in proliferative diabetic retinopathy. A strong positive correlation has been found between lipid peroxidation product and VEGF concentrations in the vitreous of patients with proliferative diabetic retinopathy [27] .
VEGF formation is controlled by oxygen supply [28, 29] , pH [30] , and glucose concentration [31] . Retinal VEGF immunoreactivity in the galactose model of diabetic retinopathy is suppressed by inhibitors of aldose reductase and non-enzymatic glycation [6] i. e. two major mechanisms contributing to ROS generation [11, 32, 33] . To determine a causal relation between diabetes-induced oxidative stress and VEGF formation, we evaluated two antioxidants, dl-a-lipoic acid and taurine, on variables of lipid peroxidation, antioxidative defence and VEGF protein and mRNA concentrations in the retinae of streptozotocin-diabetic rats with 6-week duration of diabetes. Enhanced oxidative stress and VEGF up regulation have been documented in the rat and mouse models early in the course of diabetes [34±36] . Taurine and dl-a-lipoic acid penetrate through the blood±retinal barrier [34, 37, 38] .
Materials and methods
The experiments were done in accordance with regulations specified by The Guiding Principles in the Care and Use of Animals (DHEW Publication, NIH 80±23) and the University of Michigan Protocol for Animal Studies.
Animals. Barrier-sustained, Caesarean-delivered male Wistar rats (Charles River, Wilmington, Mass., USA), body weight 250 to 300 g, were fed a standard rat chow diet (ICN Biomedicals, Cleveland, Ohio, USA) and had ad libitum access to water. Diabetes was induced by a single intraperitoneal injection of streptozotocin (55 mg/kg body weight, i. p.). Blood samples for measurements of glucose were taken from the tail vein about 48 h after streptozotocin injection and the day before the rats were killed. Rats with blood glucose of 13.9 mmol/l or more were considered diabetic. The 6-week diabetic rats were treated with or without dl-a-lipoic acid (100 mg´kg ±1´d±1 , i. p.) or taurine (1 % in the diet). Both treatments were started after diabetes was confirmed i. e. about 48 h after streptozotocin injection.
Reagents. Unless otherwise stated, all chemicals were of reagent-grade quality (Sigma Chemical, St. Louis, Mo., USA). Methanol (HPLC grade), perchloric acid, hydrochloric acid, and sodium hydroxide were purchased from Fisher Scientific, Pittsburgh, Pa., USA. Ethyl alcohol (200 proof dehydrated alcohol, U. S. P. punctilious) was purchased from McCormick Distilling, Weston, Mo., USA. b-d-Glucose, sorbitol, N. F., and d-fructose, U. S. P. were purchased from Pfanstiehl Laboratories, Waukegan, Ill., USA. [a 32 P]-UTP (800 Cu/mmol) was purchased from NEN Life Science Products, Arlington, Ill., USA. Kits for measurements of malondialdehyde (MDA) and 4-hydroxyalkenals (4-HA) were purchased from Oxis International, Portland, Ore., USA, kits for VEGF measurements and rat VEGF protein from R and D Systems, Minneapolis, Minn., USA, and bicinchoninic acid protein assay kits from Pierce, Rockford, Ill., USA.
Experimental procedure. Rats were sedated with carbon dioxide and immediately killed by cervical dislocation. Both retinae were rapidly dissected and frozen in liquid nitrogen. In experiment one, three retinae from three animals were pooled for each VEGF protein measurement. The variables MDA plus 4-HA, GSH, GSSG, DHAA, AA, taurine, glucose, sorbitol and fructose were measured in individual retinae. Taurine, GSH, GSSG, DHAA and AA concentrations were measured in control and diabetic rats treated with or without taurine. We have reported the effects of dl-a-lipoic acid on retinal oxidative stress and sorbitol pathway activity previously [34, 39] . In experiment two, individual retinae were used for measurements of VEGF mRNA.
VEGF Enzyme-Linked Immunosorbent Assay (ELISA). Material from three retinae was homogenized in 50 mmol/l Trisbuffer (pH 8.0) and centrifuged at 10 000 g for 10 min (Sorvall MC 12 V). 50 (ml-aliquots of the supernatant were used for VEGF measurements. VEGF was assayed by a sandwich ELI-SA with an affinity-purified polyclonal antibody specific for mouse VEGF according to the manufacturer's instructions. Good linearities (r mouse = 0.996 and r rat = 0.986) were obtained with this antibody and mouse and rat VEGF standards in the range of 5 to 500 pg/ml ( Fig. 1) as well as rat VEGF standards in the range of 15 to 500 pg/ml added to rat retinal homogenates (r = 0.964). The average recovery was 81 %. Intra-assay and inter-assay coefficients of variability were 3.2 2.0 and 6.4 5.5, respectively. VEGF concentrations were assayed in triplicate and normalized to total protein. For total protein measurements, 50 ml-aliquots of the retinal homogenate were mixed with 0.5 ml 0.1 N NaOH, sonicated and left overnight for complete solubilization. Proteins were quantified according to the manufacturer's instructions.
RNA preparation. Total RNA was isolated using the acid guanidium-phenol-chloroform extraction method [40] with minor modification [41] . Retinae were homogenized in 0.4 ml of guanidine isothiocyanate solution containing 4 mol/l guanidine isothiocyanate, 50 mmol/l tris-HCl, 25 mmol/l EDTA and 0.1 mol/l b-mercaptoethanol. Sequentially, 0.04 ml of 2 mol/l sodium acetate (pH 4.0), 0.4 ml of water saturated phenol and 0.08 ml of chloroform-isoamyl alcohol mixture (49:1) were added to homogenate, with thorough mixing after each reagent was added. RNA was precipitated with equal volume of 2-propanol. RNA pellets were washed with 75 % ethanol and dissolved in nuclease-free water.
Quantification of VEGF mRNA concentrations by ribonuclease protection assay. The plasmid for synthesis of the rat VEGF probe was created by synthesis of a cDNA using rat heart total RNA and oligo(dT) followed by cloning. VEGF cDNA was amplified using forward primer (5' ccggatCCTCC-GAAACCATGAACTTTCTGC-3') and reverse primer (5'-ccggaatTCTGGATTAAGGACTGTTCTGTC-3') corresponding to nucleotide sequences 46±69 and 773±751 of the human VEGF cDNA, respectively ( [42] GenBank accession number M32 977). PCR fragments of VEGF cDNA were digested with BamHI and EcoRI and cloned into plasmid pBluescript II KS + for ribonuclease protection assays. The plasmid containing VEGF cDNA was digested with XbaI to make a 735-base radiolabelled antisense probe. The plasmid for synthesis of the rat 18S probe was created by synthesis of a cDNA using rat lung total RNA using forward primer (5'-A-GATCAAAACCAACCCGG-3') and reverse primer (5'-ATTCCTAGCTGCGGTATC-3'). These oligonucleotides correspond to nucleotide sequences 236±253 and 876±859 of rat 18S rRNA, respectively ( [43] GenBank accession number M11 188). This fragment of cDNA for 18S rRNA was digested with PstI and XbaI and cloned into plasmid pBluescript II SK + for ribonuclease protection assays. This plasmid was digested with XbaI and used as a template for in vitro transcription of a 435-base radiolabelled antisense probe (predicted to protect a 372-base fragment) using T7 RNA-polymerase and [a 32 P]-UTP. The rat18S ribosomal RNA antisense probe was used to normalize VEGF gene expression to total RNA. All constructs were verified by sequencing and were found to be 100 % identical to the published sequences.
Synthesis of radiolabelled antisense probes for ribonuclease protection assay was done according to the Boehringer Mannheim protocol using T7 or T3 RNA polymerase and [a 32 P]-UTP. For ribonuclease protection assays, water solutions of total RNA were dried under vacuum and dissolved in 25 ml of 80 % formamide hybridization buffer containing labelled probes. Samples were preincubated for 5 min at 85 C and then incubated for 16 h at 45 C [29] . The extracted, protected probe fragments were run on a 6 % polyacrylamide sequencing gel in 1´Tris-borate-EDTA buffer for 2 h at 50 mA. The gel was then dried and exposed to X-ray film at ±70 C. Expression of mRNA was quantified using a PhosphorImager (Molecular Dynamics, Sunnyvale, Calif., USA). The intensity of each VEGF mRNA band was normalized for 18S ribosomal RNA level. No differences were detected between the various VEGF mRNA transcripts in the response to the different experimental conditions. Sorbitol pathway intermediates. Retinae were homogenized in 1.5 ml 0.1 mol/l sodium-phosphate buffer, pH 6.5. Then a 0.1 ml-volume of 0.3 mol/l zinc sulfate, followed by an equivalent of barium hydroxide, was added to 0.3 ml of the homogenate for protein precipitation. The samples were centrifuged at 4000 g for 10 min (Sorvall MC 12 V) and aliquots of the supernatant were taken for spectrofluorometric measurements of glucose, sorbitol and fructose by enzymatic procedures [44] .
Malondialdehyde plus 4-hydroxyalkenals, GSH and GSSG. 0.6 ml of the retinal homogenates described above were used for measurements of MDA plus 4-HA, GSH and GSSG [34] . GSH and GSSG were assayed in perchloric acid extracts. The concentrations were normalized to total protein.
DHAA and AA. 0.2 ml of the homogenates described above were mixed with 0.2 ml of ice-cold 10 % metaphosphoric acid and centrifuged at 4000 g for 10 min. For measurements of DHAA, 0.1 ml of the supernatant was mixed with 0.9 ml 2 mol/l Na-acetate buffer, pH 6.2. The reaction is started by adding 0.02 ml 92.5 mmol/l O-phenylenediamine and is completed after 30 min. The initial and final readings are taken at l excitation: 350 nm, emission: 430 nm. For measurements of total AA, 0.1 ml of the supernatant was mixed with 0.9 ml 2 mol/l Na-acetate buffer, pH 6.2 and 10 U of ascorbate oxidase to convert free AA to DHAA. The reaction is completed in 30 min. Then DHAA was quantified as described above. AA concentrations were calculated as the difference between total AA and DHAA.
Taurine. Retinal taurine concentrations were measured by reverse-phase HPLC (apparatus: Waters 501, pumps: Waters 717; autosampler: Waters 470; column: Waters 3.9´150 mm Nova-Pack C18; scanning fluorescence detector: l excitation: 360 nm; l emission: 455 nm; and Waters Millenium Software; Waters, Milford, Mass., USA) after precolumn derivatization with O-phthaldialdehyde reagent [45] (10 mg O-phthaldialdehyde dissolved in 0.2 ml absolute ethanol were mixed with 10 ml mercaptoethanol and 5 ml 0.5 mol/l borate buffer, pH 10.3). In brief, 0.1 ml of retinal homogenate described above and taurine standards in the range of 1±10´10 ±9 mol/l were extracted with 1 ml of 12 % perchloric acid and centrifuged at 4000 g for 10 min. The supernatants were purified on washed dual-bed ion-exchange columns (2.5 cm AG 1-X8 100±200 mesh; BioRad Lab., Hercules, Calif., USA; in the chloride form over 2.5 cm AG 50W-X8 200/400 mesh (Bio-Rad) in the hydrogen Fig. 1 . Representative standard curves obtained in the sandwich ELISA of murine and rat VEGF proteins with an affinity-purified polyclonal antibody specific for mouse VEGF form) by elution with 2 ml H 2 O. The eluents were washed twice with H 2 O-saturated ether and lyophilized. Samples and standards were dissolved in 100 ml H 2 O before HPLC analysis. Isocratic elution was carried out at a flow rate of 2 ml/min using 43 % solvent A ( 0.05 mol/l NaH 2 PO 4 , pH 5.3, plus 5 mol/l NaOH) combined with 57 % solvent B (0.05 mol/l NaH 2 PO 4 in 75 % methanol/H 2 O) filtered with type FH 0.5 mm Millipore filter and degassed. Glutamine, added after ion exchange chromatography, was used as the internal standard.
Statistical analysis. The results are expressed as means standard deviations. Data were subjected to equality of variance F test, and then to log transformation, if necessary, before oneway analysis of variance. When overall significance (p < 0.05) was attained, individual between-group comparisons were made using the Student-Newman-Keuls multiple range test. Statistical significance was defined as a p value of 0.05 or less. When between-group variance differences could not be normalized by log transformation, the data were analysed by the non-parametric Kruskal-Wallis one-way analysis of variance, followed by the Fisher's PLSD test for multiple comparisons.
Results
The final body weights were lower in diabetic rats than in the control group (Table 1) . The initial body weights were similar in control and diabetic groups. No statistically significant difference was found between final body weights in diabetic rats treated with taurine or dl-a-lipoic acid and the corresponding untreated groups.
Blood glucose concentration was increased 7.2-fold in diabetic rats compared with controls. Blood glucose concentrations in diabetic rats were not affected by taurine or dl-a-lipoic acid treatment.
Retinal VEGF concentration was increased 1.8-fold in diabetic rats compared with controls (Fig. 2) . This up regulation was attenuated but not completely prevented by taurine, and was completely prevented by dl-a-lipoic acid.
The ribonuclease protection assay showed two major alternatively spliced VEGF mRNA transcripts (Fig. 3A) . Retinal VEGF mRNA abundance was reduced 1.4 -fold in diabetic rats compared with controls (Fig. 3B ). This reduction was attenuated but not completely prevented by either taurine or dl-a-lipoic acid.
MDA plus 4-HA concentration was 1.6±fold higher in the retinae of diabetic rats compared with the control group (Fig. 4) . Both antioxidants arrested diabetes-induced lipid peroxidation.
Retinal taurine, GSH, GSSG, DHAA and AA concentrations were similar among control and diabetic rats treated with or without taurine ( Table 2) . Neither glutathione redox state nor ascorbate redox state (expressed as GSSG/GSH and DHAA/AA ratios, respectively) were affected by diabetes or taurine treatment.
Retinal glucose, sorbitol and fructose concentrations were 5.1-fold, 26-fold and 4.75-fold higher in diabetic rats than in the control rats (Fig. 5) . Diabetesinduced increase in retinal glucose and sorbitol pathway intermediate concentrations was not affected by dietary taurine supplementation. 
Discussion
Measurements of VEGF protein and VEGF mRNA concentrations in ocular tissues of non-diabetic animals and human subjects using in situ hybridization, blotting techniques, and immunohistochemistry resulted in contradictory findings [6, 42±46]. Absent [6, 46, 47] , weak [46, 48] or abundant [49, 50] VEGF immunoreactivity and expression have been reported by different groups. Recent development of highly sensitive ELISAs made possible precise measurements of VEGF protein concentrations in mammalian retinas [51] . Our results (calculated from the standard curve for rat VEGF) agree with those in a study using murine VEGF protein as a standard [51] . Control retinal VEGF protein concentration calculated in our study from murine VEGF standards (Fig. 1 ) was 18.9 4.68 i. e.1.6-fold lower than the one calculated from rat VEGF standards. Detection of retinal VEGF protein in non-diabetic animals ( [51] and in our study) is consistent with the physiological role for VEGF in retinal vasculogenesis and vascular development [52, 53] .
Early diabetes-induced up regulation of retinal VEGF protein, also observed in two other studies in db/db mice [35] and streptozotocin-diabetic rats [36] , temporally coincides with a decrease in retinal blood flow and impairment of retinal oxygenation [5, 12, 54] manifested in the decreased free mitochondrial and cytosolic NAD + /NADH ratios [39] . The role of oxygen as the major upstream regulatory molecule controlling VEGF production is well established and low oxygen tensions (hypoxia) have a stimulatory effect [28, 29] . Retinal VEGF up regulation is present as early as six weeks after induction of streptozotocin diabetes and thus precedes manifestations of background diabetic retinopathy. This is consistent with the findings of VEGF immunopositivity in glial cells of the retina and optic nerve in diabetic patients without vascular anatomic abnormalities [55] . The up regulation of retinal VEGF production in short-term diabetes can potentially be responsible for increased expression of the gene coding for intracellular adhesion molecule-1 and extensive leukocyte stasis [56] , A B Fig. 3 A, B. A Representative polyacrylamide gel autoradiograph obtained in the ribonuclease protection assay of VEGF mRNA and 18 S ribosomal RNA in the retinae of control rats and diabetic rats treated with or without taurine or dl-a-lipoic acid. B Retinal VEGF mRNA abundance (mean SD, n = 8 ) in the retinae of control and diabetic rats treated with or without taurine or dl-a-lipoic acid. Data were normalized to 18S ribosomal RNA levels Fig. 4 . Retinal MDA plus 4-HA concentrations in control and diabetic rats treated with or without taurine or dl-a-lipoic acid (mean SD, n = 8±10). C, controls; D, untreated diabetic group; D + T, diabetic group treated with taurine; D + LA, diabetic group treated with dl-a-lipoic acid. *significantly different vs control rats (p < 0.01); **significantly different vs untreated diabetic rats (p < 0.01) as well as decreased occludin expression with subsequent weakening of interendothelial tight junctions [24] and nonendothelial changes [56] leading to increased vascular permeability. Furthermore, VEGF activates endothelial cell p44/42 mitogen-activated protein (MAP) kinase [57] and thus is probably involved in p44/p42 MAP kinase-dependent [58] overexpression of endothelin-1 present early in the course of diabetes [54] .
Of interest, VEGF mRNA concentration was reduced rather than increased in short-term diabetes. Although most of the studies describe unidirectional changes of VEGF mRNA and VEGF protein concentrations in response to different stimuli (including strong oxidative insult in cell culture experiments [21, 22] ) and in pathological states involving angiogenesis, some reports indicate the discordance between VEGF expression at mRNA and protein level. In particular, stimulation of VEGF synthesis at low O 2 tension in human proximal tubular cells was detectable at the protein level only [59] . Stimulation of platelets with thrombin and of polymorphonuclear neutrophils with the activator of protein kinase C phorbol 12-myristate 13-acetate induced a time-dependent release of VEGF, peaking after 30 and 60 min, respectively, i. e. within the time frame insufficient to change VEGF gene expression [60] . Recently, it has been reported that phosphorylation of the initiation factor (eIF) 4E known to play an important part in the translational regulation of VEGF [61] , correlates with the activation of protein synthesis and occurs via both protein kinase C-dependent and protein kinase C-independent signalling pathways [62] . Thus, it is plausible that post-transcriptional up regulation of retinal VEGF protein in early diabetes is mediated via activation of protein kinase C [5, 7] . Correspondingly, down regulation of retinal VEGF protein concentrations by taurine and dl-a-lipoic acid could be from the inhibitory effect of antioxidants on protein kinase C activity [63] . Apparently, control of VEGF protein expression in tissue-sites for diabetic complications is complex and different components could predominate in short-term and long-term diabetes [64] .
Our data on two diverse antioxidants provides evidence of a causal relation between diabetes-induced retinal oxidative stress and VEGF protein formation in early diabetes. The role of oxidative stress in excessive retinal VEGF production in diabetes of longer duration is supported by strong positive correlations between lipid peroxidation product and VEGF protein concentrations in the vitreous of patients with proliferative diabetic retinopathy [27] , and between retinal hydrogen peroxide and VEGF concentrations in the BBZ/Wor diabetic rats examined at 4.5 to 18.0 months of diabetes [14] . In vitro studies and observations in animal models suggest that oxidative stress contributes to diabetes-induced retinal VEGF production through both hypoxia-mediated and hypoxia-independent mechanisms.
Early increase in lipid peroxidation in the retina, unlike other tissues of streptozotocin-diabetic rats [9±11, 40, 65] , occurs in the absence of glutathione [66] and in our studies, taurine and ascorbate depletion or changes in the glutathione and ascorbate redox states. Despite total arrest of diabetes-induced retinal lipid peroxidation by both antioxidants, dl-alipoic acid completely prevented, whereas taurine only attenuated, VEGF up regulation. There is no doubt that the potent free radical scavenger and metal chelator dl-a-lipoic acid [67] counteracts oxidative stress far more effectively than taurine. In addition, in biological tissues dl-a-lipoic acid is reduced to dihydrolipoate, which combines free radical (hydroxyl, superoxide, peroxyl, singlet oxygen) scavenging and metal chelating properties with the ability to regenerate concentrations of non-enzymatic and enzymatic antioxidants [34, 67, 68] . Our previous study suggests that the antioxidant effects of dl-a-lipoic acid in the retina of streptozotocin-diabetic rats are caused by free radical scavenging and metal chelating proper- ties rather than to changes in GSH and GSSG concentrations and the glutathione redox state [34] . The mechanism(s) of antioxidant activity of taurine is poorly understood although the ability of taurine to decrease diabetes-induced lipid peroxidation has been shown in several studies [40, 69, 70] . It has been reported [71, 72] that taurine decreases luminol-dependent chemiluminescence elicited by chemically generated hydroxyl radicals and t-butyl hydroperoxide whereas others [73] indicate that hypotaurine, a taurine precursor, rather than taurine itself, has antioxidative properties against ROS. Both taurine and hypotaurine scavenge hypochlorite [73] , and the retina contains the hypochlorite-producing enzyme, myeloperoxidase [74] . In addition, taurine decreases superoxide anion abundance by an unknown mechanism [75] and accelerates catabolism of norepinephrine [76] which can autoxidize and thus contribute to ROS generation. Our findings show that the antioxidant effects of taurine in the retina are not mediated through the glutathione and ascorbate systems of antioxidative defence. In addition, we could not detect any substantial increase in retinal taurine concentration in diabetic rats which were fed a taurine-supplemented diet. The retina has a remarkable capacity to maintain taurine concentration [77, 78] , and any access of retinal taurine is probably rapidly removed after the cessation of food intake.
The relation between the sorbitol pathway activity, oxidative stress and VEGF production deserves specific consideration because both structurally diverse AR inhibitors [3, 6, 79±81] and less extensively studied antioxidants [15, 82] prevent vascular abnormalities characteristic of diabetic retinopathy. Recently, it was hypothesized that oxidative stress is a cause of AR activation and sorbitol pathway intermediate accumulation in tissue-sites for diabetic complications [83] . In our study, however, retinal glucose, sorbitol and fructose concentrations were similarly increased in diabetic rats fed regular and taurine-supplemented diets. Furthermore, dl-a-lipoic acid which is known to increase glucose transport [84, 85] by facilitating translocation of glucose transporters towards the plasma membrane [84] , exacerbates diabetes-induced retinal sorbitol pathway intermediate accumulation [39] . The absence of any suppression of the sorbitol pathway activity by two diverse antioxidants, both of which arrest lipid peroxidation and neutralize superoxide anion radicals [67, 75] , suggests that oxidative stress is not likely to be the cause of retinal sorbitol pathway metabolite accumulation in diabetes. The arrest of VEGF production by dl-a-lipoic acid and taurine, both of which counteract oxidative stress but do not suppress the sorbitol pathway hyperactivity, does not contradict an important role for AR in VEGF up regulation. Our findings are consistent with downstream localization of diabetes-associated oxidative stress consequent to increased AR activity [11, 32, 86±89] which, therefore, renders VEGF up regulation preventable by both AR inhibitors [6] and antioxidants.
In conclusion, oxidative stress causes increased VEGF production in the retina in early diabetes. This up regulation is detectable at the protein, but not mRNA level. The findings support the rationale for evaluating potent antioxidants, such as dl-a-lipoic acid, dietary antioxidant mixtures and antioxidantcontaining combination therapies to prevent the onset or progression of diabetic retinopathy. 
